The Photosynthetic Microbes team from the University of Turku received over 900 000 € to build a large algae plant for the validation of cultivation processes in the Nordic environment. The team will grow microalgae in drain water from greenhouses to clean water, recover nutrients and lower microalgae production costs.
The universities in Turku launched in autumn 2021 a joint webinar series focusing on technology and sustainable development. Aboa Tech Talks will highlight new technologies and innovative technological research that can offer solutions to the complex global challenges of our time.
Registration to BioCity Symposium is open until 11 August 2022. BioCity Symposium is one of the most important meetings in Turku region for researchers working in the fields of bio- and molecular medicine. This year the event is arranged together with InFLAMES Flagship with title Solution is in Immunity.
The universities in Turku, in close collaboration with Turku Science Park, have launched a joint Aboa Tech Talks webinar series this autumn focusing on emerging technologies and sustainable development. Aboa Tech Talks aims to highlight advanced and innovative technological research and education carried in the universities that can offer sustainable solutions to the complex global challenges of our time.
The annual BioCity Symposium is in August 19th–20th with the title Cancer – Breaking Bad. This series of meetings organized since 1991 has become the most important annual get-together in the fields of biosciences and molecular medicine in Turku. The symposium gathers together hundreds of participants each year and offers talks from cutting-edge international researchers.
SORLA is a protein trafficking receptor that has been mainly studied in neurons, but it also plays a role in cancer cells. Professor Johanna Ivaska’s research group at Turku Bioscience observed that SORLA functionally contributes to the most reported therapy-resistant mechanism by which the cell-surface receptor HER3 counteracts HER2 targeting therapy in HER2-positive cancers. Removing SORLA from cancer cells sensitised anti-HER2 resistant breast cancer brain metastasis to targeted therapy.
Academy Professor in Molecular Plant Biology, Academician of Science Eva-Mari Aro and Director of the Research Centre of Applied and Preventive Cardiovascular Medicine, Academy Professor Olli Raitakari are among the most cited researchers in the world. Clarivate Analytics has published its annual list of Highly Cited Researchers whose citation records position them in the top one percent by citations for their field and year.
The Department of Life Technologies is an international and multifaceted educational and research unit that combines various fields of biosciences. Teaching is based on extensive basic research as well as on applied research related to cellular and molecular-level structures and processes. The information is utilized in medicine, food development, analytics and the development of environmentally friendly technologies.
At the Department of Life Technologies we conduct high-quality research that focuses on structure and function of proteins, photosynthesis and bioenergetics, in vitro diagnostics, and food sciences.